Peroxisome Proliferator-Activated Receptor γ Controls Ingestive Behavior, Agouti-Related Protein, and Neuropeptide Y mRNA in the Arcuate Hypothalamus

Peroxisome proliferator-activated receptor γ (PPARγ) is clinically targeted for type II diabetes treatment; however, rosiglitazone (ROSI), a PPARγ agonist, increases food intake and body/fat mass as side-effects. Mechanisms for these effects and the role of PPARγ in feeding are not understood. There...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Neurosci
Auteurs principaux: Garretson, John T., Teubner, Brett J.W., Grove, Kevin L., Vazdarjanova, Almira, Ryu, Vitaly, Bartness, Timothy J.
Format: Artigo
Langue:Inglês
Publié: Society for Neuroscience 2015
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4363385/
https://ncbi.nlm.nih.gov/pubmed/25788674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.2129-14.2015
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires